BioNTech SE: Form 20-F/A for the period ended Dec 31, 2021
Filed with the SEC on Oct 26, 2022 and accepted by EDGAR at Oct 26, 2022, 17:20 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2021-01-01 to 2021-12-31 | EUR 18.98bn | ifrs-full:RevenueFromContractsWithCustomers |
| Cost of revenue | 12 months2021-01-01 to 2021-12-31 | EUR 2.91bn | ifrs-full:CostOfSales |
| Operating income | 12 months2021-01-01 to 2021-12-31 | EUR 15.28bn | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months2021-01-01 to 2021-12-31 | EUR 4.75bn | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months2021-01-01 to 2021-12-31 | EUR 10.29bn | ifrs-full:ProfitLossAttributableToOwnersOfParent |
| Diluted EPS | 12 months2021-01-01 to 2021-12-31 | EUR 39.63 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months2021-01-01 to 2021-12-31 | EUR 42.18 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months2021-01-01 to 2021-12-31 | EUR 889.7m | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months2021-01-01 to 2021-12-31 | EUR 127.5m | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | At period end2021-12-31 | EUR 1.69bn | ifrs-full:CashAndCashEquivalents |
| Current assets | At period end2021-12-31 | EUR 15.07bn | ifrs-full:CurrentAssets |
| Total assets | At period end2021-12-31 | EUR 15.83bn | ifrs-full:Assets |
| Current liabilities | At period end2021-12-31 | EUR 3.48bn | ifrs-full:CurrentLiabilities |
| Total liabilities | At period end2021-12-31 | EUR 3.94bn | ifrs-full:Liabilities |
| Shareholders' equity | At period end2021-12-31 | EUR 11.89bn | ifrs-full:Equity |
Source: SEC EDGAR, the filing index for accession 0000950170-22-020213. Last ingested by Listed: Nov 3, 2026, 08:40 ET. Listed shows no prices and gives no investment advice.